Both in Biotechnology
Repligen vs Bio-Techne
Over the past year RGEN returned +56.8% and TECH returned +38.6%; their daily moves had a correlation of 0.54.
RGEN +56.8% TECH +38.6%Growth of $1, one year, split-adjusted
| Metric | RGEN | TECH |
|---|---|---|
| Price | $194.57 | $72.38 |
| Market cap | $10.98B | $11.35B |
| Today | +0.25% | −0.18% |
| 1 month | +10.4% | 0.0% |
| 6 months | +74.5% | +39.1% |
| Year to date | +18.7% | +23.1% |
| 1 year | +54.9% | +39.6% |
| Revenue growth (YoY) | +11.9% | +1.3% |
| Gross margin | 53.9% | 65.8% |
| Net margin | 2.5% | 17.0% |
| P/E (TTM) | 264.3× | 62.4× |
| Price / sales | 14.0× | 9.3× |
| Net cash | $259.4M | $64.7M |
| Dividend yield | — | 0.44% |
| Volatility (60d) | 43.0% | 3.7% |
| Short % of float | 12.0% | 4.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).